FGFR2 and invasive lobular breast carcinoma: By contrast, the majority of Fgfr2ΔE18 glands contained FGFR2-positive high-grade adenocarcinomas or E-cadherin-negative invasive lobular carcinomas or sarcomatoid tumours (Extended Data Fig. 8).